Evidence map›Paper›PMID 36600108›Full record

ArticleMolecular biology reports2023

Association between iron metabolism and SARS-COV-2 infection, determined by ferritin, hephaestin and hypoxia-induced factor-1 alpha levels in COVID-19 patients.

Elif Sibel Aslan, Hüseyin Aydın, Yusuf Kenan Tekin, Sami Keleş, Kenneth N White, Nezih Hekim

Open access · bronzeAbstract read
In one paragraph

Article in Molecular biology reports, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it, 7 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 2 countries.

Elif Sibel AslanMolecular Biology and Genetic Department, Faculty of Engineering and Natural Sciences, Biruni University, 10. Yıl Street. Protokol Road, Topkapı, Istanbul, Turkey. easlan@biruni.edu.tr.ORCID http://orcid.org/0000-0002-3081-9004
Hüseyin AydınMedical Biochemistry, Department of Basic Medical Sciences, Sivas Cumhuriyet University, Sivas, Turkey.ORCID http://orcid.org/0000-0002-3194-830X
Yusuf Kenan TekinMedical Biochemistry, Department of Basic Medical Sciences, Sivas Cumhuriyet University, Sivas, Turkey.ORCID http://orcid.org/0000-0001-8047-4836
Sami KeleşAhenk Medical Diagnosis and Research Laboratory, Yeditepe University, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-0177-3649
Kenneth N WhiteMolecular Systems for Health Research Group, School of Human Sciences, London Metropolitan University, London, UK.ORCID http://orcid.org/0000-0002-6103-9078
Nezih HekimMolecular Biology and Genetic Department, Faculty of Engineering and Natural Sciences, Biruni University, 10. Yıl Street. Protokol Road, Topkapı, Istanbul, Turkey.ORCID http://orcid.org/0000-0003-2613-8676
Biruni University · TRSivas Cumhuriyet Üniversitesi · TRLondon Metropolitan University · GBYeditepe University · TR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundDue to the growing evidence of the importance of iron status in immune responses, the biomarkers of iron metabolism are of interest in novel Coronavirus Disease 2019 (COVID-19). The present prospective study was carried out to compare iron status indicated by levels of ferritin with the levels of two novel biomarkers related to iron homeostasis, hephaestin and hypoxia-inducible factors-1 (HIF-1α) in the serum of patients with COVID-19 in comparison with a control group. METHODS AND

resultsBlood samples from 34 COVID-19 patients and from 43 healthy volunteers were collected and the levels of HEPH and HIF-1α were measured by ELISA and compared with levels of serum ferritin. COVID-19 patients had higher serum levels of ferritin than those levels in control group (P < 0.0001). Conversely levels of HIF-1α and HEPH in the COVID-19 group were significantly lower than those of control group (P < 0.0001 for both). An inverse correlation between hephaestin and ferritin as well as between HIF-1α and ferritin was found among all subjects (P < 0.0001), and among COVID-19 patients, but not to statistical significance.

conclusionLevels of hephaestin and HIF-1α were found to be inversely related levels of ferritin across all participants in the study, and to our knowledge this is the first report of hephaestin and HIF-1α as potential markers of iron status. Further studies are needed to corroborate the findings, utilizing a broader range of markers to monitor inflammatory as well as iron status.

Indexed as

COVID-19FerritinsHumansHypoxiaHypoxia-Inducible Factor 1, alpha SubunitIronMembrane ProteinsProspective StudiesSARS-CoV-2FerritinsHEPH protein, humanHIF1A protein, humanHypoxia-Inducible Factor 1, alpha SubunitIronMembrane ProteinsCOVID-19FerritinHephaestinHypoxia inducible factor 1-alfa (HIF-1α)Iron metabolism

Identifiers

PMID36600108
PMCPMC9812738
OpenAlexW4313490290

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.